Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFMW) Long-Term Deferred Tax (2023 - 2025)

Historic Long-Term Deferred Tax for Sunshine Biopharma (SBFMW) over the last 3 years, with Q3 2025 value amounting to $92234.0.

  • Sunshine Biopharma's Long-Term Deferred Tax changed N/A to $92234.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $92234.0, marking a year-over-year change of. This contributed to the annual value of $92234.0 for FY2024, which is 4782.08% down from last year.
  • According to the latest figures from Q3 2025, Sunshine Biopharma's Long-Term Deferred Tax is $92234.0.
  • In the past 5 years, Sunshine Biopharma's Long-Term Deferred Tax registered a high of $176764.0 during Q4 2023, and its lowest value of $92234.0 during Q4 2024.
  • Over the past 3 years, Sunshine Biopharma's median Long-Term Deferred Tax value was $92234.0 (recorded in 2024), while the average stood at $109140.0.
  • Examining YoY changes over the last 5 years, Sunshine Biopharma's Long-Term Deferred Tax showed a top increase of 4782.08% in 2024 and a maximum decrease of 4782.08% in 2024.
  • Sunshine Biopharma's Long-Term Deferred Tax (Quarter) stood at $176764.0 in 2023, then crashed by 47.82% to $92234.0 in 2024, then changed by 0.0% to $92234.0 in 2025.
  • Its last three reported values are $92234.0 in Q3 2025, $92234.0 for Q2 2025, and $92234.0 during Q1 2025.